OGDEN, Utah--(BUSINESS WIRE)--Setpoint Systems (http://www.setpointusa.com), a leader in design and manufacture of custom lean automation solutions and manufacturing ...
Northwell Health was one of many who conducted a pioneering clinical trial to treat rheumatoid arthritis through a chip implanted on the vagus nerve. The first technology of its kind yielded ...
Credit: SetPoint Medical. The SetPoint System is a rechargeable neurostimulation device that is implanted on the vagus nerve. Treatment with the SetPoint System, a neuroimmune modulation device, was ...
An innovative new device calms inflammation by delivering a low-voltage jolt of electricity to the vagus nerve. The FDA has approved the SetPoint System, a device implanted in the neck for relieving ...
Milestone underscores continued momentum in commercial rollout and accelerating adoption of neuroimmune modulation as a new option for adults living with Rheumatoid Arthritis "The SetPoint System ...
The U.S. Food and Drug Administration (FDA) has granted approval to the SetPoint System, a neuroimmune modulation device designed to treat adults with moderate-to-severe rheumatoid arthritis (RA).
Procedures performed by Dr. Webster Crowley mark a milestone for neuroimmune modulation therapy in the Midwest SetPoint Medical today announced the first patients in Chicago have been treated with the ...
Hosted on MSN
Device Implanted in the Neck May Ease RA Symptoms
The FDA has approved the SetPoint System, a device implanted in the neck for relieving rheumatoid arthritis symptoms that aren’t adequately managed by medication. The device uses a daily low-voltage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results